Welcome to Ozempic Weightloss Unlocked, where we dive into the latest news on Ozempic from medical breakthroughs to real-life health impacts.
Semaglutide, the active ingredient in Ozempic, is showing surprising mental health perks. A large study by researchers from the University of Eastern Finland, Karolinska Institutet, and Griffith University, published in The Lancet Psychiatry, found users had 42 percent fewer psychiatric hospital visits and 44 percent lower depression risk during treatment. Anxiety dropped 38 percent, substance use disorders fell 47 percent, and suicidal behavior risks decreased too. Science Daily reports these benefits may stem from lifestyle changes or direct brain effects.
On the innovation front, Eli Lilly's oral pill orforglipron outperformed oral semaglutide in a 52-week phase three trial with 1698 adults with type two diabetes. Science Alert details how orforglipron cut blood sugar more, dropping HbA1c by 1.71 to 1.91 percent versus 1.47 percent, and spurred greater weight loss of 6.1 to 8.2 kilograms compared to 5.3 kilograms. Though more side effects like nausea led to higher dropouts, it's a promising needle-free rival.
Stopping Ozempic? A Cleveland Clinic study of nearly eight thousand patients in Diabetes, Obesity and Metabolism challenges rebound fears. Those treated for obesity lost 8.4 percent body weight before stopping and regained just 0.5 percent after one year. Many restarted meds, switched treatments, or adopted lifestyle changes, with 45 percent maintaining or losing more weight.
Heart and kidney wins continue: Johns Hopkins Public Health notes GLP-one drugs cut five-year risks of heart attacks and end-stage kidney disease by 15 percent in type one diabetes patients.
Exercise matters too. Outside Online highlights a study where aerobic activity preserved muscle during 29-pound average losses on GLP-ones.
Long-term, these drugs boost metabolic health, reduce inflammation, and may extend longevity via sustained weight loss, per Health Central and experts like James Hill from the University of Alabama.
Real users report two-thirds fewer cravings, per 2026 data from engineering Cambridge.
Thanks for tuning in, listeners. Subscribe for more updates. This has been a Quiet Please production, for more check out quietplease.ai.
Some great Deals https://amzn.to/49SJ3Qs
For more check out http://www.quietplease.ai
This content was created in partnership and with the help of Artificial Intelligence AI.
